Bbrain cancer drug targets the IDH mutation (IMAGE)

Johns Hopkins Medicine

Bbrain cancer drug targets the IDH mutation

Caption

FDA approves brain cancer drug, targeting the IDH mutation discovered at the Johns Hopkins Kimmel Cancer Center.

Credit

Elizabeth Cook

Usage Restrictions

NONE

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.